Earlier quoted context omitted.
You are looking at this from the wrong perspective. If people start spreading this attenuated strain around on their own what are the regulatory agencies going to do? Even if you wanted to go down the regulatory pathway for some reason it still has a number of advantages over other approaches. 1. We would know it is safe in humans before we began. 2. We would know what mutations make the virus less pathogenic. 3. Onc…
> What are regulatory agencies going to to do? If you were to start doing this without regulatory approval, the most likely outcomes seems that you’d be arrested [1]. Do you have anything that suggests otherwise? > 1. We would know it is safe in humans before we began. The regulatory requirements for “knowing it is safe in humans” are currently quite high. As things stand, I would expect trials to be required. Can yo…
As we have seen with the whole HCQ fiasco regulations have a habit of getting lowered once there is data, even poor data. If we contact trace everyone who has been infected with the attenuated strain we will get some good data on the safety of the strain. It might not be 100% safe, and we might have some questions, but that is a discussion we can have once we find the strain.
We need to make some hard choices here between certainty and action. Waiting for certainty is a choice that carries a very high cost.